John A. Williams

Pfizer (United States), University of Bath

Papers

2

Total Citations

307

H-Index

2

About

John A. Williams is a multidisciplinary researcher whose work bridges bioanalytical chemistry and robotic locomotion. He is best known for his seminal contribution to pharmaceutical science: the development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding. This 2003 paper, with over 300 citations, revolutionized high-throughput drug screening by enabling rapid, reliable assessment of drug-protein interactions—a critical parameter in pharmacokinetics and drug discovery. The apparatus became a standard tool in laboratories worldwide, significantly accelerating early-stage drug development. In a striking departure, Williams also explored biomimetic robotics, proposing a novel approach to robot locomotion in unstructured and slippery environments (2005). Though less cited, this work demonstrates his versatility and willingness to tackle fundamental challenges in engineering. While his bioanalytical innovation remains his most impactful achievement, his career exemplifies how a single, elegantly designed tool can transform a field. Williams’ legacy is a testament to the power of practical, problem-solving research that directly addresses industry needs.

Research Focus

Key Achievements

2
H-Index
2
Papers
307
Total Citations
154
Avg Citations/Paper
🏆 Most Cited Paper
Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding
302 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Pfizer (United States), University of Bath

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago